SlideShare ist ein Scribd-Unternehmen logo
1 von 33
Mohammed Adel, B.Sc., PharmD
Clinical Pharmacy Department
Al-Ahrar General Hospital
Antibiotics:
Optimization of use & excellence of
outcome
1
• Principles of antibiotic use
• Time dependent activity
• Conc. Dependent activity
• Dual activity
• Indications for prophylaxis
Content
2
• Vancomycin:
• Mechanism of action
• Indications
• Dosing
• ADR
Content
3
Principles of antibiotic use
4
Drug
Dose
Delivery
Duration
De-escalation
Principles of antibiotic use
• Prevent infectionProphylactic
• Abort infectionPreemptive
• Initial control of infectionEmpiric
• Cure infection of know
etiology
Definitive
5
Principles of antibiotic use
• Prevent endocarditis
• Surgical prophylaxis
Prophylactic
• Against cytomegalovirus in
immune suppressed Pts
Preemptive
• CAP / HAP / VAPEmpiric
• Known etiologic organism &
susceptibility
Definitive
6
Pt= Patient CAP= Community Acquired pneumonia HAP= Hospital Acquired pneumonia VAP=Ventilator Acquired pneumonia
Principles of antibiotic use
7
• Initiate appropriate Abx therapy ASAP
Every 1 Hr delay = 8% increase in mortality
• Be aware of the site of infection
Local control
Treating most likely organism
ABX= antibiotics ASAP= as soon as possible
Principles of antibiotic use
8
• Possibility of resistance
Abx exposure
Known resistant colonization
Exposure to heath care facilities
Local Abx resistance pattern
• Host factor:
Allergy
Organ function status
ABX= antibiotics
Principles of antibiotic use
9
• Severity of illness
Using IV vs PO
Choosing upper end of the dosing range
Consider loading dose
Consider combination therapy
ABX= antibiotics IV= Intravenous
PO= Oral route
Principles of antibiotic use
10
• Treat infection… not colonization
• Cultures before Abx
Without delay
• Administer the 1st dose ASAP
• Monitor response to your Abx therapy
After 48-72 Hrs
Take routine Abx time out
ABX= antibiotics ASAP= as soon as possible
Principles of antibiotic use
11
• What is time out??
– Time out is the check point at which the
physician should answer these questions:
Does this patient have an infection that will respond
to antibiotics?
Is the patient on the right antibiotic(s), dose, and
route of administration?
Principles of antibiotic use
12
• What is time out??
– Time out is the check point at which the
physician should answer these questions:
Can a more targeted antibiotic be used to treat the
infection?
How long should the patient receive the
antibiotic(s)?
Principles of antibiotic use
13
• Re-evaluation of therapy depends on:
– Clinical response
– Microbiologic data
Organism ID
Local anti-biogram
Isolate susceptibility
Principles of antibiotic use
14
Chk your Pt
-ve Culture
No change Worse Improved
+ve Culture
Optimize
Principles of antibiotic use
15
Improving pt
Re-evaluate
the dose
Evaluate
Adverse
effects
1- If culture +ve: refine
your regimen
2- If culture –ve:
decide the duration
Principles of antibiotic use
16
Refining / de-
escalating
regimen
• Resolve bug drug mismatch
• Plan the likely duration
• De-escalation:
• Narrowing spectrum
• Eliminate redundancies
• Consider PO route
Time dependent activity
17
• Antibiotic needs more time to achieve 99.9% kill
target
• Serum conc. Is not important
• Observed in:
– β-lactams
– Macrolides
– Clindamycin
– Glycopeptides
• How to optimize time dependent effect?
18
Time dependent activity
Concentration dependent activity
19
• Antibiotic needs higher concentration to
achieve 99.9% kill target
• Time of exposure Is not important
• Observed in:
– Aminoglycosides
– Fluoroquinolones
– Daptomycin
– Metronidazole
• How to optimize conc. dependent effect?
Concentration dependent activity
20
This is Genta !
:D
Concentration dependent activity
21
Which kill
better?
Mixed pattern activity
22
• Fluoroquinolones differs in it’s pattern
• It uses AUC24:MIC ratio
– For gm -ve ---< 125 for Cipro/Levo
– For gm +ve ---< 30 for Levo
23
Mixed pattern activity
Also:
Daptomycin
Tigecycline
vancomycin
Indications for antibiotic prophylaxis
24
• Before dental procedures against IE
• Before surgical procedures
• Before GI endoscopy
• For SBP
• For recurrent UTI
IE= infective endocarditis GI= Gastro-intestinal SBP=
Spontaneous Bacterial Pretonitis UTI= Urinary tract infection
Vancomycin
25
• Glycopeptide antibiotic
• Mostly effective against Gm+ve Bacteria
• Always reserved for complicated or multidrug
resistant infections
• Characterized with mixed time/concentration killing
pattern
Vancomycin
26
Vancomycin
27
• Against MRSA in HAP/VAP
• For bacterial IE
• GI chemosterlization (PO)
• Prosthetic joint infection
• CDAD
HAP= Hospital Acquired Pneumonia VAP= Ventilator Acquired Pneumonia IE=Infective
Endocarditis GI=Gastrointestinal
CDAD=C.difficile-Associated Diarrhea
Vancomycin
28
• Manufacturer’s labeling:
Usual dose: 500 mg every 6 hours or 1,000 mg
every 12 hours
• Alternate recommendations*:
15 to 20 mg/kg/dose every 8 to 12 hours
*(ASHP/IDSA/SIDP [Rybak, 2009]);
Vancomycin
29
• *Complicated infections in seriously ill
patients:
A loading dose of 25 to 30 mg/kg (based on
actual body weight)
*(ASHP/IDSA/SIDP [Rybak, 2009]);
Vancomycin
30
• Injection:
– More than10%:
Cardiovascular: Hypotension accompanied by flushing
Dermatologic: Erythematous rash on face and upper
body (red neck or red man syndrome - infusion rate
related)
Vancomycin
31
• Injection:
– From 1% to 10%:
Central nervous system: Chills, drug fever
Dermatologic: Rash
Hematologic: Eosinophilia, reversible neutropenia
Local: Phlebitis
Vancomycin
32
• Oral:
– More than10%:
Gastrointestinal: Abdominal pain, bad taste (with
oral solution), nausea
33

Weitere ähnliche Inhalte

Was ist angesagt?

Guidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxisGuidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxisDrLakshmiGayathripha
 
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...John Blue
 
Antibiotic Policy - An Overview
Antibiotic Policy - An OverviewAntibiotic Policy - An Overview
Antibiotic Policy - An OverviewSourabh Mandwariya
 
Rational use of antibiotics & antibiotic policy
Rational use of antibiotics & antibiotic policyRational use of antibiotics & antibiotic policy
Rational use of antibiotics & antibiotic policyVikas Sharma
 
Principle of antibiotic prophylaxis
Principle of antibiotic prophylaxisPrinciple of antibiotic prophylaxis
Principle of antibiotic prophylaxisHidayat Shariff
 
Pregnancy in clinical research
Pregnancy in clinical researchPregnancy in clinical research
Pregnancy in clinical researchPriti Gupta
 
Antibiotic prophylaxis
Antibiotic prophylaxisAntibiotic prophylaxis
Antibiotic prophylaxisAditi Singh
 
ICAAC 2014: Selection of sessions and abstracts
ICAAC 2014: Selection of sessions and abstractsICAAC 2014: Selection of sessions and abstracts
ICAAC 2014: Selection of sessions and abstractsPROANTIBIOTICOS
 
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Dr. Jagadeesh Mangamoori
 
Antibiotic stewardship program in children
Antibiotic stewardship program in childrenAntibiotic stewardship program in children
Antibiotic stewardship program in childrenAzad Haleem
 

Was ist angesagt? (19)

Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
The National Antibiotic Guidelines: Shepherding Clinicians towards Rational u...
 
Guidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxisGuidelines for rational use of antibiotics in surgical prophylaxis
Guidelines for rational use of antibiotics in surgical prophylaxis
 
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antibiotic Policy - An Overview
Antibiotic Policy - An OverviewAntibiotic Policy - An Overview
Antibiotic Policy - An Overview
 
Rational use of antibiotics & antibiotic policy
Rational use of antibiotics & antibiotic policyRational use of antibiotics & antibiotic policy
Rational use of antibiotics & antibiotic policy
 
Surgical prophylaxis
Surgical prophylaxisSurgical prophylaxis
Surgical prophylaxis
 
It's More Fun Doing the Antibiogram
It's More Fun Doing the AntibiogramIt's More Fun Doing the Antibiogram
It's More Fun Doing the Antibiogram
 
Principle of antibiotic prophylaxis
Principle of antibiotic prophylaxisPrinciple of antibiotic prophylaxis
Principle of antibiotic prophylaxis
 
Pregnancy in clinical research
Pregnancy in clinical researchPregnancy in clinical research
Pregnancy in clinical research
 
Diagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policyDiagnostic microbiology in Antibiotic policy
Diagnostic microbiology in Antibiotic policy
 
Antibiotic prophylaxis
Antibiotic prophylaxisAntibiotic prophylaxis
Antibiotic prophylaxis
 
ICAAC 2014: Selection of sessions and abstracts
ICAAC 2014: Selection of sessions and abstractsICAAC 2014: Selection of sessions and abstracts
ICAAC 2014: Selection of sessions and abstracts
 
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...
 
Antibiotic stewardship program in children
Antibiotic stewardship program in childrenAntibiotic stewardship program in children
Antibiotic stewardship program in children
 
Safety Data Generation
Safety Data GenerationSafety Data Generation
Safety Data Generation
 

Andere mochten auch

Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012hospital
 
heart failure updated
heart failure updatedheart failure updated
heart failure updatedMohammed Adel
 
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramCardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramFarjad Ikram
 
Anise as estrogenic agent
Anise as estrogenic agentAnise as estrogenic agent
Anise as estrogenic agentTaher Haddad
 
Ventilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewVentilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewGeoffrey Bird
 
IV drug preparation Open heart
IV drug preparation Open heartIV drug preparation Open heart
IV drug preparation Open heartMohammed Adel
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentationTaher Haddad
 
Ihab Suliman
Ihab SulimanIhab Suliman
Ihab Sulimanhospital
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesDr. Abhimanyu Prashar
 
Project Heart Presentation(Students)
Project Heart Presentation(Students)Project Heart Presentation(Students)
Project Heart Presentation(Students)nurjohari
 
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramCardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramFarjad Ikram
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1Mohammed Adel
 

Andere mochten auch (20)

cover + presented
cover + presentedcover + presented
cover + presented
 
Amitrityline overdose.pptx1
Amitrityline overdose.pptx1Amitrityline overdose.pptx1
Amitrityline overdose.pptx1
 
1contents
1contents1contents
1contents
 
cardio case (2)
cardio case (2)cardio case (2)
cardio case (2)
 
Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012
 
colts foot
colts footcolts foot
colts foot
 
heart failure updated
heart failure updatedheart failure updated
heart failure updated
 
pediatrics case VSD
pediatrics case VSDpediatrics case VSD
pediatrics case VSD
 
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramCardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
 
Anise as estrogenic agent
Anise as estrogenic agentAnise as estrogenic agent
Anise as estrogenic agent
 
Ventilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewVentilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based review
 
LVF with HTN and T2DM and PD
LVF with HTN and T2DM and PDLVF with HTN and T2DM and PD
LVF with HTN and T2DM and PD
 
IV drug preparation Open heart
IV drug preparation Open heartIV drug preparation Open heart
IV drug preparation Open heart
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
Ihab Suliman
Ihab SulimanIhab Suliman
Ihab Suliman
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & Responsibilities
 
Project Heart Presentation(Students)
Project Heart Presentation(Students)Project Heart Presentation(Students)
Project Heart Presentation(Students)
 
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramCardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
 

Ähnlich wie Antibiotics 1

Prinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.pptPrinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.pptUnnayanRaj
 
Antibiotic use in surgery
Antibiotic use in surgeryAntibiotic use in surgery
Antibiotic use in surgeryAlade Olubunmi
 
Principle of antibiotic use.pptx
Principle of antibiotic use.pptxPrinciple of antibiotic use.pptx
Principle of antibiotic use.pptxOlofin Kayode
 
Antimicrobial stewardship.pptx
Antimicrobial stewardship.pptxAntimicrobial stewardship.pptx
Antimicrobial stewardship.pptxJosephMalinda1
 
Antibiotics treatment & management
Antibiotics treatment & management Antibiotics treatment & management
Antibiotics treatment & management Baiti Basheer
 
074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdf074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdfAmar Prasad
 
Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Tahseen Siddiqui
 
9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROsYaser Ammar
 
Antimicrobial Stewardship 2014
Antimicrobial Stewardship 2014Antimicrobial Stewardship 2014
Antimicrobial Stewardship 2014BBrauer25
 
Antimicrobial stewardship 2014 (1)
Antimicrobial stewardship 2014 (1)Antimicrobial stewardship 2014 (1)
Antimicrobial stewardship 2014 (1)BBrauer25
 
General principles of antimicrobial therapy
General principles of antimicrobial therapyGeneral principles of antimicrobial therapy
General principles of antimicrobial therapyAbialbon Paul
 
antibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptxantibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptxRebumaMegersa1
 
AMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdfAMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdfSanjayaManiDixit
 
Antibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in childrenAntibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in childrenAzad Haleem
 
Optimizing antibiotic therapy in icu setting
Optimizing antibiotic therapy in icu settingOptimizing antibiotic therapy in icu setting
Optimizing antibiotic therapy in icu settingMahen Kothalawala
 

Ähnlich wie Antibiotics 1 (20)

Prinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.pptPrinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.ppt
 
Antibiotic use in surgery
Antibiotic use in surgeryAntibiotic use in surgery
Antibiotic use in surgery
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
 
Principle of antibiotic use.pptx
Principle of antibiotic use.pptxPrinciple of antibiotic use.pptx
Principle of antibiotic use.pptx
 
Antimicrobial stewardship.pptx
Antimicrobial stewardship.pptxAntimicrobial stewardship.pptx
Antimicrobial stewardship.pptx
 
Antibiotics treatment & management
Antibiotics treatment & management Antibiotics treatment & management
Antibiotics treatment & management
 
074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdf074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdf
 
Update on HAP and VAp
Update on HAP and VApUpdate on HAP and VAp
Update on HAP and VAp
 
Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19Antimicrobial stewardship CME 04-03-19
Antimicrobial stewardship CME 04-03-19
 
9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs9 nosocomial pneumonia combating MDROs
9 nosocomial pneumonia combating MDROs
 
Principles of antibiotic therapy
Principles of antibiotic therapyPrinciples of antibiotic therapy
Principles of antibiotic therapy
 
Ama for BPH 2017
Ama for BPH 2017Ama for BPH 2017
Ama for BPH 2017
 
Antimicrobial Stewardship 2014
Antimicrobial Stewardship 2014Antimicrobial Stewardship 2014
Antimicrobial Stewardship 2014
 
Antimicrobial stewardship 2014 (1)
Antimicrobial stewardship 2014 (1)Antimicrobial stewardship 2014 (1)
Antimicrobial stewardship 2014 (1)
 
General principles of antimicrobial therapy
General principles of antimicrobial therapyGeneral principles of antimicrobial therapy
General principles of antimicrobial therapy
 
antibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptxantibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptx
 
AMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdfAMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdf
 
Antibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in childrenAntibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in children
 
Optimizing antibiotic therapy in icu setting
Optimizing antibiotic therapy in icu settingOptimizing antibiotic therapy in icu setting
Optimizing antibiotic therapy in icu setting
 
antibiotic resistance whats new???
antibiotic resistance  whats new???antibiotic resistance  whats new???
antibiotic resistance whats new???
 

Mehr von Mohammed Adel

UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxMohammed Adel
 
METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)Mohammed Adel
 
Diabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalDiabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalMohammed Adel
 

Mehr von Mohammed Adel (6)

UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinux
 
Bitter Melon
Bitter MelonBitter Melon
Bitter Melon
 
angina presentation
angina presentationangina presentation
angina presentation
 
streptogramin final
streptogramin finalstreptogramin final
streptogramin final
 
METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)
 
Diabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalDiabetic Keto-Acidosis final
Diabetic Keto-Acidosis final
 

Antibiotics 1

  • 1. Mohammed Adel, B.Sc., PharmD Clinical Pharmacy Department Al-Ahrar General Hospital Antibiotics: Optimization of use & excellence of outcome 1
  • 2. • Principles of antibiotic use • Time dependent activity • Conc. Dependent activity • Dual activity • Indications for prophylaxis Content 2
  • 3. • Vancomycin: • Mechanism of action • Indications • Dosing • ADR Content 3
  • 4. Principles of antibiotic use 4 Drug Dose Delivery Duration De-escalation
  • 5. Principles of antibiotic use • Prevent infectionProphylactic • Abort infectionPreemptive • Initial control of infectionEmpiric • Cure infection of know etiology Definitive 5
  • 6. Principles of antibiotic use • Prevent endocarditis • Surgical prophylaxis Prophylactic • Against cytomegalovirus in immune suppressed Pts Preemptive • CAP / HAP / VAPEmpiric • Known etiologic organism & susceptibility Definitive 6 Pt= Patient CAP= Community Acquired pneumonia HAP= Hospital Acquired pneumonia VAP=Ventilator Acquired pneumonia
  • 7. Principles of antibiotic use 7 • Initiate appropriate Abx therapy ASAP Every 1 Hr delay = 8% increase in mortality • Be aware of the site of infection Local control Treating most likely organism ABX= antibiotics ASAP= as soon as possible
  • 8. Principles of antibiotic use 8 • Possibility of resistance Abx exposure Known resistant colonization Exposure to heath care facilities Local Abx resistance pattern • Host factor: Allergy Organ function status ABX= antibiotics
  • 9. Principles of antibiotic use 9 • Severity of illness Using IV vs PO Choosing upper end of the dosing range Consider loading dose Consider combination therapy ABX= antibiotics IV= Intravenous PO= Oral route
  • 10. Principles of antibiotic use 10 • Treat infection… not colonization • Cultures before Abx Without delay • Administer the 1st dose ASAP • Monitor response to your Abx therapy After 48-72 Hrs Take routine Abx time out ABX= antibiotics ASAP= as soon as possible
  • 11. Principles of antibiotic use 11 • What is time out?? – Time out is the check point at which the physician should answer these questions: Does this patient have an infection that will respond to antibiotics? Is the patient on the right antibiotic(s), dose, and route of administration?
  • 12. Principles of antibiotic use 12 • What is time out?? – Time out is the check point at which the physician should answer these questions: Can a more targeted antibiotic be used to treat the infection? How long should the patient receive the antibiotic(s)?
  • 13. Principles of antibiotic use 13 • Re-evaluation of therapy depends on: – Clinical response – Microbiologic data Organism ID Local anti-biogram Isolate susceptibility
  • 14. Principles of antibiotic use 14 Chk your Pt -ve Culture No change Worse Improved +ve Culture Optimize
  • 15. Principles of antibiotic use 15 Improving pt Re-evaluate the dose Evaluate Adverse effects 1- If culture +ve: refine your regimen 2- If culture –ve: decide the duration
  • 16. Principles of antibiotic use 16 Refining / de- escalating regimen • Resolve bug drug mismatch • Plan the likely duration • De-escalation: • Narrowing spectrum • Eliminate redundancies • Consider PO route
  • 17. Time dependent activity 17 • Antibiotic needs more time to achieve 99.9% kill target • Serum conc. Is not important • Observed in: – β-lactams – Macrolides – Clindamycin – Glycopeptides • How to optimize time dependent effect?
  • 19. Concentration dependent activity 19 • Antibiotic needs higher concentration to achieve 99.9% kill target • Time of exposure Is not important • Observed in: – Aminoglycosides – Fluoroquinolones – Daptomycin – Metronidazole • How to optimize conc. dependent effect?
  • 22. Mixed pattern activity 22 • Fluoroquinolones differs in it’s pattern • It uses AUC24:MIC ratio – For gm -ve ---< 125 for Cipro/Levo – For gm +ve ---< 30 for Levo
  • 24. Indications for antibiotic prophylaxis 24 • Before dental procedures against IE • Before surgical procedures • Before GI endoscopy • For SBP • For recurrent UTI IE= infective endocarditis GI= Gastro-intestinal SBP= Spontaneous Bacterial Pretonitis UTI= Urinary tract infection
  • 25. Vancomycin 25 • Glycopeptide antibiotic • Mostly effective against Gm+ve Bacteria • Always reserved for complicated or multidrug resistant infections • Characterized with mixed time/concentration killing pattern
  • 27. Vancomycin 27 • Against MRSA in HAP/VAP • For bacterial IE • GI chemosterlization (PO) • Prosthetic joint infection • CDAD HAP= Hospital Acquired Pneumonia VAP= Ventilator Acquired Pneumonia IE=Infective Endocarditis GI=Gastrointestinal CDAD=C.difficile-Associated Diarrhea
  • 28. Vancomycin 28 • Manufacturer’s labeling: Usual dose: 500 mg every 6 hours or 1,000 mg every 12 hours • Alternate recommendations*: 15 to 20 mg/kg/dose every 8 to 12 hours *(ASHP/IDSA/SIDP [Rybak, 2009]);
  • 29. Vancomycin 29 • *Complicated infections in seriously ill patients: A loading dose of 25 to 30 mg/kg (based on actual body weight) *(ASHP/IDSA/SIDP [Rybak, 2009]);
  • 30. Vancomycin 30 • Injection: – More than10%: Cardiovascular: Hypotension accompanied by flushing Dermatologic: Erythematous rash on face and upper body (red neck or red man syndrome - infusion rate related)
  • 31. Vancomycin 31 • Injection: – From 1% to 10%: Central nervous system: Chills, drug fever Dermatologic: Rash Hematologic: Eosinophilia, reversible neutropenia Local: Phlebitis
  • 32. Vancomycin 32 • Oral: – More than10%: Gastrointestinal: Abdominal pain, bad taste (with oral solution), nausea
  • 33. 33

Hinweis der Redaktion

  1. Appropriate means that organism is susciptible to it Every hr
  2. Colonization with resistant organisms
  3. Colonization with resistant organisms
  4. Colonization with resistant organisms
  5. Colonization with resistant organisms
  6. Colonization with resistant organisms
  7. Colonization with resistant organisms
  8. Colonization with resistant organisms
  9. Colonization with resistant organisms
  10. Colonization with resistant organisms
  11. Bacteriostatic when MIC is 35-45% of cephalosporin 30% penicillin 40% carbepenims --- but if exposure become cidal when to mic 60-70% cephalosporins 50% peniocillins- 40% carbepenims --------------------- to optimize time dependent activity: increase dose or frequency or duration of infusion
  12. Bacteriostatic when MIC is 35-45% of cephalosporin 30% penicillin 40% carbepenims --- but if exposure become cidal when to mic 60-70% cephalosporins 50% peniocillins- 40% carbepenims --------------------- to optimize time dependent activity: increase dose or frequency or duration of infusion
  13. Genta Q8hrs better Q24hrs Cmax:MIC ration 8:10
  14. Genta Q8hrs better Q24hrs Cmax:MIC ration 8:10
  15. Genta Q8hrs better Q24hrs Cmax:MIC ration 8:10
  16. Bacteriostatic when MIC is 35-45% of cephalosporin 30% penicillin 40% carbepenims --- but if exposure become cidal when to mic 60-70% cephalosporins 50% peniocillins- 40% carbepenims --------------------- to optimize time dependent activity: increase dose or frequency or duration of infusion